4 min read
ASCO 2026: RAS Is No Longer Undruggable
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
Join Veristat and other experienced clinical quality, operations, management and audit professionals at the 8th Clincial Quality Oversight Forum to discuss the successes, challenges and experiences collaborating with clinical partners all while maintaining clinical trial quality and integrity.
The forum will highlight many topics including:
Veristat’s head of Corporate Compliance & Quality will be attending this event. Introduce yourself to her or you can pre-schedule a meeting with her by filling out the form on the right hand side of this page.
To learn more about Veristat’s commitment to quality and corporate compliance, read our latest blog post which discusses the implementation of our new electronic Trial Master File (eTMF) system.
4 min read
Jun 15, 2026 Veristat News
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
10 min read
Jun 12, 2026 Veristat Blog
This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and gene therapy, clinical...